Session Tracks

Conference session tracks

The ICNDDT features a diverse range of session tracks covering key research areas, emerging trends and interdisciplinary innovations within the field of Neurology. Each track gives researchers, academicians, industry professionals and practitioners a platform to present their work, exchange ideas and explore the advancements shaping the future of the domain.

This conference contributes to global sustainability by aligning its research discussions and academic sessions with the United Nations Sustainable Development Goals, fostering knowledge exchange, innovation and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
SDG 10
SDG 10 Reduced Inequalities
SDG 16
SDG 16 Peace, Justice and Strong Institutions
01
Track

Pathophysiology of Neurodegenerative Diseases

This session will explore the underlying biological mechanisms that contribute to neurodegenerative diseases. Emphasis will be placed on recent discoveries in cellular and molecular pathways involved in conditions such as Alzheimer's and Parkinson's.

02
Track

Innovative Therapeutic Approaches

This track will focus on novel therapeutic strategies for managing neurodegenerative diseases. Presentations will cover cutting-edge research in drug development, gene therapy, and personalized medicine.

03
Track

Neuroinflammation and Neurodegeneration

This session will examine the role of neuroinflammation in the progression of neurodegenerative diseases. Discussions will highlight the interplay between immune responses and neuronal health.

04
Track

Cognitive Impairment in Neurodegenerative Disorders

This track will delve into the cognitive deficits associated with various neurodegenerative diseases. Research findings on assessment tools and interventions aimed at improving cognitive function will be presented.

05
Track

Biomarkers for Early Diagnosis

This session will focus on the identification and validation of biomarkers for early detection of neurodegenerative diseases. The importance of biomarkers in clinical trials and patient management will also be discussed.

06
Track

Neuroprotective Strategies

This track will explore strategies aimed at protecting neuronal cells from degeneration. Topics will include pharmacological agents, lifestyle interventions, and their implications for patient care.

07
Track

Patient-Centered Approaches in Neurology

This session will emphasize the importance of patient-centered care in the management of neurodegenerative diseases. Discussions will include the integration of patient preferences and experiences into therapeutic decision-making.

08
Track

Advancements in Neuroimaging Techniques

This track will highlight the latest advancements in neuroimaging technologies for studying neurodegenerative diseases. Presentations will focus on how these techniques enhance our understanding of disease progression and treatment efficacy.

09
Track

Genetic and Environmental Risk Factors

This session will investigate the genetic and environmental factors contributing to the risk of developing neurodegenerative diseases. The interplay between genetic predisposition and lifestyle choices will be a key focus.

10
Track

Ethical Considerations in Neurodegenerative Research

This track will address the ethical challenges associated with research in neurodegenerative diseases. Discussions will include informed consent, patient autonomy, and the implications of emerging therapies.

11
Track

Future Directions in Neurodegenerative Disease Research

This session will explore future research directions and emerging trends in the field of neurodegenerative diseases. Participants will discuss potential breakthroughs and the impact of interdisciplinary approaches on therapeutic development.